These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 2866396

  • 41. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.
    Lok AS, Hadziyannis SJ, Weller IV, Karvountzis MG, Monjardino J, Karayiannis P, Montano L, Thomas HC.
    Gut; 1984 Nov; 25(11):1283-7. PubMed ID: 6500366
    [Abstract] [Full Text] [Related]

  • 42. Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside.
    Fowler MJ, Monjardino J, Weller IV, Lok AS, Thomas HC.
    Gut; 1984 Jun; 25(6):611-8. PubMed ID: 6203813
    [Abstract] [Full Text] [Related]

  • 43. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E, Tsuji T, Kachi K, Kagawa K, Okanoue T, Takino T, Yamada A, Imanishi J.
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [Abstract] [Full Text] [Related]

  • 44. Interferon therapy in the chronic aggressive viral hepatitis.
    Voiculescu M.
    Med Interne; 1990 Mar; 28(3):187-98. PubMed ID: 1709292
    [Abstract] [Full Text] [Related]

  • 45. Therapy of chronic viral hepatitis.
    Main J.
    J Hosp Infect; 1991 Jun; 18 Suppl A():335-40. PubMed ID: 1716277
    [Abstract] [Full Text] [Related]

  • 46. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G, Villanova N, Abdu-Ahmed M, Barbara L, Saracco G, Rizzetto M, Cancellieri C, Roda E.
    Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868
    [Abstract] [Full Text] [Related]

  • 47. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B, Stalder GA, Gudat F, Bianchi L, Froesner GG.
    Schweiz Med Wochenschr; 1982 Apr 12; 112(15):523-4. PubMed ID: 7079688
    [Abstract] [Full Text] [Related]

  • 48. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection.
    Brook MG, Petrovic L, McDonald JA, Scheuer PJ, Thomas HC.
    J Hepatol; 1989 Mar 12; 8(2):218-25. PubMed ID: 2469711
    [Abstract] [Full Text] [Related]

  • 49. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH, Beames MP, Kuhns MC, Hoofnagle JH, Di Bisceglie AM.
    Am J Gastroenterol; 1996 Nov 12; 91(11):2323-8. PubMed ID: 8931411
    [Abstract] [Full Text] [Related]

  • 50. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
    Scullard GH, Andres LL, Greenberg HB, Smith JL, Sawhney VK, Neal EA, Mahal AS, Popper H, Merigan TC, Robinson WS, Gregory PB.
    Hepatology; 1981 Nov 12; 1(3):228-32. PubMed ID: 6169615
    [No Abstract] [Full Text] [Related]

  • 51. [HBe antigen and its antibodies in acute and chronic hepatitis B].
    Vorozhbieva TE, Ketiladze ES, Maynard JE, Murphy GL, Farber NA.
    Vopr Virusol; 1984 Nov 12; 29(2):167-72. PubMed ID: 6375136
    [Abstract] [Full Text] [Related]

  • 52. Lymphoblastoid alpha-interferon weekly, daily and combined with acyclovir for chronic HBeAg-positive hepatitis.
    Schalm SW, Heytink RA, Van Buuren HR, De Man RA.
    J Hepatol; 1986 Nov 12; 3 Suppl 2():S189-92. PubMed ID: 3598156
    [Abstract] [Full Text] [Related]

  • 53. Characterization of the transcripts of hepatitis D and B viruses in infected human livers.
    Chen PJ, Yang PM, Chen CR, Chen DS.
    J Infect Dis; 1989 Dec 12; 160(6):944-7. PubMed ID: 2584763
    [Abstract] [Full Text] [Related]

  • 54. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S, Paulij W, Meisel H, Will H.
    Virology; 1998 Apr 25; 244(1):146-60. PubMed ID: 9581787
    [Abstract] [Full Text] [Related]

  • 55. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors.
    Brook MG, Karayiannis P, Thomas HC.
    Hepatology; 1989 Nov 25; 10(5):761-3. PubMed ID: 2680866
    [Abstract] [Full Text] [Related]

  • 56. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK, Ayaz C, Hosoglu S, Geyik MF, Ulug M.
    Saudi Med J; 2006 May 25; 27(5):617-20. PubMed ID: 16680248
    [Abstract] [Full Text] [Related]

  • 57. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M, Pântea V, Cebotarescu V, Cojuhari L, Jimbei P, Albrecht J, Schmid P, Le Gal F, Gordien E, Krawczyk A, Mijočević H, Karimzadeh H, Roggendorf M, Vaillant A.
    Lancet Gastroenterol Hepatol; 2017 Dec 25; 2(12):877-889. PubMed ID: 28964701
    [Abstract] [Full Text] [Related]

  • 58. [Prognostic value of HBe antigen and anti-HBe antibody in viral hepatitis B (author's transl)].
    Chossegros P, Trepo C, Brette R, Chevallier P, Vitviski L, Sepetjan M.
    Nouv Presse Med; 1981 May 30; 10(24):1993-6. PubMed ID: 7255135
    [Abstract] [Full Text] [Related]

  • 59. Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.
    Takano S, Omata M, Yokosuka O, Imazeki F, Ohto M.
    Dig Dis Sci; 1992 Nov 30; 37(11):1633-43. PubMed ID: 1425062
    [Abstract] [Full Text] [Related]

  • 60. Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.
    Madalinski K, Burczynska B, Heermann KH, Uy A, Gerlich WH.
    Clin Exp Immunol; 1991 Jun 30; 84(3):493-500. PubMed ID: 2044231
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.